* Ekso Bionics Holdings Inc reported a quarterly adjusted loss of 10 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -24 cents. The mean expectation of two analysts for the quarter was for a loss of 10 cents per share. Wall Street expected results to range from -13 cents to -8 cents per share.

* Revenue fell 10.4% to $4.13 million from a year ago; analysts expected $5.55 million.

* Ekso Bionics Holdings Inc's reported EPS for the quarter was a loss of 10 cents​.

* The company reported a quarterly loss of $2.07 million.

* Ekso Bionics Holdings Inc shares had fallen by 10.3% this quarter and lost 58.4% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts was unchanged in the last three months.​

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Ekso Bionics Holdings Inc is $6.25 This summary was machine generated from LSEG data October 29 at 02:34 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 -0.10 -0.10 Met

Jun. 30 2024 -0.13 -0.13 Met

Mar. 31 2024 -0.16 -0.20 Missed

Dec. 31 2023 -0.11 -0.22 Missed